Can an experimental or investigational denial go to external review?

Yes, federal consumer guidance expressly lists a plan determination that treatment is experimental or investigational as a type of denial eligible for external review. A purely contractual eligibility or benefit-exclusion dispute may be treated differently, so follow the final denial notice.

What should I request from the plan before appealing?

Request the exact plan definition, the clinical policy and version used, the scientific or clinical rationale applied to your circumstances, and the records, rules, protocols, and expert information relevant to the decision. Rights and procedures vary by plan type; employer-plan participants can consult U.S. Department of Labor guidance.

What evidence belongs in the appeal?

Ask the treating clinician to address the plan's criteria point by point using your diagnosis, treatment history, why alternatives are unsuitable, the proposed treatment's regulatory status and indication when relevant, current specialty guidelines, and the most applicable peer-reviewed evidence.

“Experimental or investigational” denial: make the plan show its work

UPDATED JULY 2026 · U.S. COMMERCIAL PLANS · NOT LEGAL OR MEDICAL ADVICE

This label is a plan determination, not a complete explanation. A useful appeal starts with the exact plan definition and clinical policy, then asks your treating clinician to address those criteria with evidence specific to your condition. Federal consumer guidance expressly recognizes this denial type for internal appeal and independent external review.

What the federal process gives you

An “experimental” or “investigational” denial can be challenged through an internal appeal.
This determination is expressly listed as eligible for external review under federal consumer standards.
For many employer plans, the notice must explain the scientific or clinical judgment applied to your circumstances or offer that explanation free on request.
The denial notice and plan documents control the exact filing route, deadline, and plan-specific definition.

Step 1 — Get the definition, policy, and complete rationale

Do not answer a one-line label with a generic letter. Ask the plan or administrator, in writing, for:

The exact plan provision defining experimental, investigational, unproven, or not evidence based.
The complete clinical policy, protocol, or guideline used, including its version and effective date.
The scientific or clinical judgment applying that policy to your diagnosis and proposed treatment.
Documents and records relevant to the decision and, where available under your plan's rules, information about medical experts consulted.
The treatment and diagnosis codes used to decide the claim.

The U.S. Department of Labor's claim-and-appeal guide explains these disclosure rights for private-sector employer health plans governed by ERISA. Other coverage uses its own notice and regulator, so follow your plan documents.

Step 2 — Ask the treating clinician to answer the policy

The clinician — not a template — should decide which medical evidence is relevant. A focused supporting letter can address:

Your diagnosis, severity, treatment history, and objective findings.
Why covered alternatives have failed, are contraindicated, or are unsuitable in your case.
How the requested treatment fits the plan's own criteria, including any disputed term.
Regulatory status and labeled indication, when relevant, without treating approval status alone as proof of coverage.
Current specialty-society guidelines and the most applicable peer-reviewed studies, with full citations.
The expected clinical consequences of delay, using case-specific facts rather than promises of an outcome.

Step 3 — Check whether this is really a clinical-trial cost dispute

Coverage of an investigational treatment itself is different from coverage of routine patient costs during a trial. For certain qualified people participating in approved clinical trials for cancer or another life-threatening disease or condition, federal rules can protect participation and routine patient costs. Eligibility, plan scope, and the definition of routine costs are specific. See the CMS clinical-trial coverage guidance, and ask your plan, state insurance regulator, or the Department of Labor which rules govern your coverage.

The appeal letter

Free template — experimental / investigational denial

[Your name] · Member ID: [ID] Claim / Authorization #: [number] · [Date] [Plan / insurer] — Appeals Department [Address or portal from denial notice] RE: Appeal of “experimental / investigational” denial — [treatment], denied [date] To the Appeals Department: I appeal the denial of [treatment] for [diagnosis]. The notice states: "[quote the complete denial reason]." Please review the enclosed evidence under the exact terms of my plan and the clinical policy used for this decision. 1. PLAN DEFINITION AND CRITERIA. The applicable plan language states: "[quote the definition or coverage provision]." The requested treatment satisfies or is not excluded by that language because [address each relevant element; do not make unsupported medical claims]. 2. CASE-SPECIFIC CLINICAL RATIONALE. My treating clinician, Dr. [name and specialty], explains that [brief summary]. The enclosed letter addresses my diagnosis, objective findings, prior treatments, and why alternatives are unsuitable. 3. SUPPORTING EVIDENCE. The enclosed [guideline / regulatory material / peer-reviewed studies] is relevant because [clinician's explanation connecting the evidence to this patient and the plan criterion]. 4. [IF APPLICABLE] APPROVED CLINICAL-TRIAL ROUTINE COSTS. This request concerns [identify routine patient costs, not the investigational item itself]. Enclosed are the trial information and clinician's statement regarding eligibility and appropriateness. Please reverse the denial and authorize or cover [treatment/service]. If you uphold it, provide the complete scientific or clinical judgment, every plan provision and policy relied upon, the records relevant to the decision, and the instructions and deadline for independent external review. Enclosed: denial notice; treating-clinician letter; relevant medical records; plan and clinical-policy excerpts; supporting evidence with citations; clinical-trial documents, if applicable. Sincerely, [Signature] · [Name] · [Phone]

If delay would create serious medical risk

Ask the treating clinician whether the facts meet the plan's urgent-review standard. HealthCare.gov states that when the standard timeline would seriously jeopardize life or the ability to regain maximum function, a person may request an expedited internal appeal and external review at the same time. See the current process details in the external review guide; availability and filing routes can change.

Build from the policy, not the label

Upload the denial and organize the evidence.

GetMyYes drafts a case-specific appeal framework, a request for the plan's clinical rationale, and a clinician-letter checklist. Your treating clinician should review all medical statements before filing.

Start my appeal — free preview

FREE PREVIEW · $39 FULL PACKET · NO SUBSCRIPTION. EVER.

Frequently asked questions

Does FDA approval automatically require my plan to cover the treatment?

No single fact automatically resolves plan coverage. Regulatory status may be important evidence, but the appeal still needs to address the plan's benefit language, clinical policy, indication, and your individual medical circumstances.

Can I submit new studies during external review?

Under the HHS-administered federal process, claimants may submit additional information for the reviewer to consider if it is submitted by the applicable filing deadline. State and plan-contracted processes may have their own instructions, so use the destination and deadline in the final denial.

What if the plan simply excludes the entire benefit?

A pure contractual eligibility or benefit-exclusion dispute may not qualify for the same federal medical external-review path. Request the exact plan provision and follow the final denial's appeal instructions. A state Consumer Assistance Program, state regulator, or the Department of Labor can help identify the correct route for your plan type.